Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort

Background: Alzheimer's disease (AD) is the most common form of dementia, and early diagnosis is crucial to enable effective interventions. Currently, Alzheimer's disease is diagnosed through cognitive assessments, brain imaging and fluid biomarkers focused on determining amyloid (A) and, tau (T) pr...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Tobias Sikosek, Marco Heuvelman, Jagoda Mika, Mustafa Kahraman, Julia Jehn, Maurice Frank, Alberto Daniel-Moreno, Jessika Ceiler, Jasmin Skottke, Marta Sanchez-Delgado, Patrick Neubert, Christina Rudolf, Kaja Tikk, Rastislav Horos, Jeffrey L. Cummings, Josie Butchart, Craig Ritchie, Jean Manson, Bruno R. Steinkraus
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2025-09-01
Rangatū:	The Journal of Prevention of Alzheimer's Disease
Ngā marau:	European Prevention for Alzheimer’s Dementia (EPAD) Early Onset Alzheimer’s Disease (EOAD) Mild Cognitive Impairment (MCI) Blood RNA biomarker Machine learning AT(N) framework
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2274580725002006
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!